Main > ONCOLOGY (**) > Ovarian Cancer MET Pt-Sensitive *** > Indication > Co: USA. C. Brand Amifostine Inj.>

---

Co: USA. C. Brand Amifostine Inj.>'s subsections
(*) USA Launch Date: 2016. 09.26
>CisPlatin Renal Toxicity Reduction
Company/Licensee
Licensor
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 14
Patent>UpDate: 2007. 04.17
Patent>USA Expiration: 2013. 07.29
TradeMark (USA)
TradeMark (USA) Web-Site

Co: USA. C. Brand Amifostine Inj.>'s products
This section has no products